Severe Sepsis Completed Phase 2 Trials for Ascorbic acid (DB00126)

Also known as: Sepsis, Severe

IndicationStatusPhase
DBCOND0031268 (Severe Sepsis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03422159Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in Sepsis.Treatment